Neumoloxía
Servizo
Universidad Autónoma de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (27)
2024
-
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia
2023
-
A Study of the Prevalence of Asthma in the General Population in Spain
Open Respiratory Archives, Vol. 5, Núm. 2
-
Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value
Respiratory Research, Vol. 24, Núm. 1
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
-
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81
-
The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients’ Life – The Spanish Patients’ Perspective
Journal of Asthma and Allergy, Vol. 16, pp. 461-471
-
Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724
2022
-
Pertussis Vaccine in COPD and Asthma: An Old Acquaintance Is Back
Open Respiratory Archives
-
Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study
Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674
-
Whooping Cough: The Visible Enemy
Archivos de Bronconeumologia
-
[Translated article] Whooping Cough: The Visible Enemy
Archivos de Bronconeumologia
2021
-
Alterations in respiratory function test three months after hospitalisation for covid-19 pneumonia: Value of determining nitric oxide diffusion
Journal of Clinical Medicine, Vol. 10, Núm. 10
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
-
SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases
Open Respiratory Archives, Vol. 3, Núm. 2
-
SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseases
Vacunas, Vol. 22, Núm. 3, pp. 131-134
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068